Skip to main content
Quest Diagnostics

Herpes Simplex Virus (HSV) Type-Specific IgG Antibodies

Test code(s) 6447, 3636X, 3640

A positive result strongly suggests a recent or past HSV infection. The person may be capable of transmitting the virus to others.

A small percentage of positive HSV-2 IgG results may be false-positive.1 Further testing may be appropriate for patients with a low or unexpected positive HSV-2 IgG result. The HSV-2 IgG Inhibition, ELISA performed at Quest Diagnostics Infectious Disease can be used to further characterize the sample and distinguish a false-positive from a true-positive result. Contact your local Quest Diagnostics laboratory to order this test.

Not necessarily. A negative result does not rule out infection, because the specimen may have been collected before antibodies reached detectable levels.2 This assay can detect HSV IgG antibodies as early as 3 weeks after the onset of symptoms.2 However, people seroconvert at different rates, and some do not seroconvert for 6 months or longer.2

Additionally, a very small percentage (0.2%) of HSV-2 isolates lack glycoprotein G (gG).3 When the infecting HSV isolate is gG deficient, a false-negative result may occur.

 

References

  1. Aurelian, L. Herpes simplex viruses. In: Specter S, and Lanoz GL, eds. Clinical Virology Manual. 2nd ed. New York: Elsevier; 1992:473-497.
  2. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis. 2003;30:310-314.
  3. Liljeqvist JA, Svennerholm B, Bergström T. Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies. J Clin Microbiol. 1999;37:2727-2718.

 

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

Document FAQS.118 Version: 0
Version 1 effective 03/24/2017 to present
Version 0 effective 12/02/2013 to 03/24/2017

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.